{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:31:18Z","timestamp":1790199078952,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD095741"],"award-info":[{"award-number":["R01HD095741"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gonadal hormones can modify immune function, which may impact susceptibility to infectious diseases, including Human Immunodeficiency Virus (HIV). There is limited knowledge about how hormonal contraceptives (HC) influence the immune response during the course of use. The CHIME study aims to evaluate the effect of long-acting progestin-based hormonal contraceptives (depot medroxyprogesterone acetate, etonogestrel implant, and levonorgestrel intrauterine device) on immunologic changes in the female genital tract (FGT) and systemic compartment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>CHIME is an observational cohort study where participants attend 2 visits prior to initiating the HC method of their choice, and then attend 6 visits over 12\u00a0months with biological sampling (vaginal swabs, cervicovaginal lavage, cytobrush and blood) for immunological, bacteriological, and virological analyses at each visit. Immune profiling will be evaluated by multi-color flow cytometry to determine how different T-cell subsets, in particular the CD4 T-cell subsets, change during the course of contraceptive use and whether they have different profiles in the FGT compared to the systemic compartment. The study aims are (1) to characterize the alterations in FGT and systemic immune profiles associated with three long-acting progestin-only HC and (2) to evaluate the vaginal microenvironment, determined by 16\u00a0s rRNA sequencing, as an individual-level risk factor and moderator of genital and systemic immune profile changes following exposure to three commonly used HC. Data collection started in March 2019 and is scheduled to be completed in October 2024.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The CHIME study aims to contribute to the body of research designed to evaluate the comparative impact of three long-acting progestin-only HC on innate and adaptive immune functions to understand how immunologic effects alter STI and HIV susceptibility.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-022-02053-w","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T12:03:05Z","timestamp":1668772985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluating the impact of three progestin-based hormonal contraceptive methods on immunologic changes in the female genital tract and systemically (CHIME Study): a prospective cohort study protocol"],"prefix":"10.1186","volume":"22","author":[{"given":"Lisa B.","family":"Haddad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina Bailey","family":"Herring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Christina","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyree","family":"Staple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakthivel","family":"Govindaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayakumar","family":"Velu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"issue":"3","key":"2053_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1728-4465.2014.00393.x","volume":"45","author":"G Sedgh","year":"2014","unstructured":"Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies worldwide in 2012 and recent trends. Stud Fam Plann. 2014;45(3):301\u201314.","journal-title":"Stud Fam Plann"},{"key":"2053_CR2","unstructured":"World Health Organization (WHO). Family Planning\/Contraception Fact Sheet http:\/\/who.int\/mediacentre\/factsheets\/fs351\/en\/2017 [updated 7\/2017. Available from: http:\/\/who.int\/mediacentre\/factsheets\/fs351\/en\/."},{"key":"2053_CR3","volume-title":"Family Planning Worldwide 2008 Data Sheet","author":"Population Reference Bureau","year":"2008","unstructured":"Population Reference Bureau. Family Planning Worldwide 2008 Data Sheet. Washington, DC: Population Reference Bureau; 2008."},{"key":"2053_CR4","unstructured":"United Nations & Department of Economic and Social Affairs Population Division. World Contraceptive Use 2010 Chart. 2010."},{"issue":"17","key":"2053_CR5","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1097\/QAD.0000000000001228","volume":"30","author":"CB Polis","year":"2016","unstructured":"Polis CB, Curtis KM, Hannaford PC, Phillips SJ, Chipato T, Kiarie JN, et al. An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women. AIDS. 2016;30(17):2665\u201383.","journal-title":"AIDS"},{"issue":"10195","key":"2053_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(19)31288-7","volume":"394","author":"K Ahmed","year":"2019","unstructured":"Ahmed K, Baeten JM, Beksinska M, Bekker L-G, Bukusi EA, Donnell D, et al. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Lancet. 2019;394(10195):303\u201313.","journal-title":"Lancet"},{"issue":"4","key":"2053_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.contraception.2011.06.006","volume":"84","author":"D Africander","year":"2011","unstructured":"Africander D, Louw R, Verhoog N, Noeth D, Hapgood JP. Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract. Contraception. 2011;84(4):423\u201335.","journal-title":"Contraception"},{"issue":"7","key":"2053_CR8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","volume":"76","author":"D Africander","year":"2011","unstructured":"Africander D, Verhoog N, Hapgood JP. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception. Steroids. 2011;76(7):636\u201352.","journal-title":"Steroids"},{"issue":"5","key":"2053_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1056\/NEJMcp1608736","volume":"376","author":"KM Curtis","year":"2017","unstructured":"Curtis KM, Peipert JF. Long-Acting Reversible Contraception. N Engl J Med. 2017;376(5):461\u20138.","journal-title":"N Engl J Med"},{"issue":"5 Suppl","key":"2053_CR10","first-page":"381","volume":"41","author":"DR Mishell Jr","year":"1996","unstructured":"Mishell DR Jr. Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med. 1996;41(5 Suppl):381\u201390.","journal-title":"J Reprod Med"},{"issue":"5","key":"2053_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.contraception.2005.05.018","volume":"72","author":"A Ildgruben","year":"2005","unstructured":"Ildgruben A, Sjoberg I, Hammarstrom ML, Backstrom T. Steroid receptor expression in vaginal epithelium of healthy fertile women and influences of hormonal contraceptive usage. Contraception. 2005;72(5):383\u201392.","journal-title":"Contraception"},{"issue":"3","key":"2053_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0010-7824(80)90003-7","volume":"21","author":"CG Nilsson","year":"1980","unstructured":"Nilsson CG, Lahteenmaki P, Luukkainen T. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD. Contraception. 1980;21(3):225\u201333.","journal-title":"Contraception"},{"issue":"49","key":"2053_CR13","doi-asserted-by":"publisher","first-page":"20877","DOI":"10.1073\/pnas.0911796106","volume":"106","author":"C Cicala","year":"2009","unstructured":"Cicala C, Martinelli E, McNally JP, Goode DJ, Gopaul R, Hiatt J, et al. The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A. 2009;106(49):20877\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2053_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ni1566","volume":"9","author":"J Arthos","year":"2008","unstructured":"Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, Wei D, et al. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol. 2008;9(3):301\u20139.","journal-title":"Nat Immunol"},{"issue":"6","key":"2053_CR15","doi-asserted-by":"publisher","first-page":"e0178193","DOI":"10.1371\/journal.pone.0178193","volume":"12","author":"SS Iyer","year":"2017","unstructured":"Iyer SS, Sabula MJ, Mehta CC, Haddad LB, Brown NL, Amara RR, et al. Characteristics of HIV target CD4 T cells collected using different sampling methods from the genital tract of HIV seronegative women. PLoS ONE. 2017;12(6):e0178193.","journal-title":"PLoS ONE"},{"issue":"7","key":"2053_CR16","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nm.4105","volume":"22","author":"M Vaccari","year":"2016","unstructured":"Vaccari M, Gordon SN, Fourati S, Schifanella L, Liyanage NP, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22(7):762\u201370.","journal-title":"Nat Med"},{"issue":"2","key":"2053_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/aji.12209","volume":"72","author":"K Murphy","year":"2014","unstructured":"Murphy K, Irvin SC, Herold BC. Research gaps in defining the biological link between HIV risk and hormonal contraception. Am J Reprod Immunol. 2014;72(2):228\u201335.","journal-title":"Am J Reprod Immunol"},{"key":"2053_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12948-016-0048-x","volume":"14","author":"MP Piccinni","year":"2016","unstructured":"Piccinni MP, Lombardelli L, Logiodice F, Kullolli O, Parronchi P, Romagnani S. How pregnancy can affect autoimmune diseases progression? Clin Mol Allergy. 2016;14:11.","journal-title":"Clin Mol Allergy"},{"issue":"9","key":"2053_CR19","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1007\/s10620-015-3683-z","volume":"60","author":"T Adar","year":"2015","unstructured":"Adar T, Grisaru-Granovsky S, Ben Ya\u2019acov A, Goldin E, Bar-Gil SA. Pregnancy and the Immune System: General Overview and the Gastroenterological Perspective. Dig Dis Sci. 2015;60(9):2581\u20139.","journal-title":"Dig Dis Sci"},{"issue":"24","key":"2053_CR20","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1016\/S0264-410X(03)00331-1","volume":"21","author":"P Luppi","year":"2003","unstructured":"Luppi P. How immune mechanisms are affected by pregnancy. Vaccine. 2003;21(24):3352\u20137.","journal-title":"Vaccine"},{"key":"2053_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1749-6632.1998.tb09547.x","volume":"840","author":"RL Wilder","year":"1998","unstructured":"Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann N Y Acad Sci. 1998;840:45\u201350.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2053_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1600-0897.2007.00504.x","volume":"58","author":"MM Barousse","year":"2007","unstructured":"Barousse MM, Theall KP, Van Der Pol B, Fortenberry JD, Orr DP, Fidel PL Jr. Susceptibility of middle adolescent females to sexually transmitted infections: impact of hormone contraception and sexual behaviors on vaginal immunity. Am J Reprod Immunol. 2007;58(2):159\u201368.","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"2053_CR23","first-page":"590","volume":"215","author":"KD Birse","year":"2017","unstructured":"Birse KD, Romas LM, Guthrie BL, Nilsson P, Bosire R, Kiarie J, et al. Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices. J Infect Dis. 2017;215(4):590\u20138.","journal-title":"J Infect Dis"},{"issue":"4","key":"2053_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1473-3099(15)00429-6","volume":"16","author":"EH Byrne","year":"2016","unstructured":"Byrne EH, Anahtar MN, Cohen KE, Moodley A, Padavattan N, Ismail N, et al. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study. Lancet Infect Dis. 2016;16(4):441\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2053_CR25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1089\/aid.2012.0271","volume":"29","author":"N Chandra","year":"2013","unstructured":"Chandra N, Thurman AR, Anderson S, Cunningham TD, Yousefieh N, Mauck C, et al. Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues. AIDS Res Hum Retroviruses. 2013;29(3):592\u2013601.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"2053_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/aji.12415","volume":"74","author":"J Deese","year":"2015","unstructured":"Deese J, Masson L, Miller W, Cohen M, Morrison C, Wang M, et al. Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract. Am J Reprod Immunol. 2015;74(4):357\u201367.","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"2053_CR27","doi-asserted-by":"publisher","first-page":"e00221","DOI":"10.1128\/mBio.00221-15","volume":"6","author":"RN Fichorova","year":"2015","unstructured":"Fichorova RN, Chen PL, Morrison CS, Doncel GF, Mendonca K, Kwok C, et al. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception. MBio. 2015;6(5):e00221-e315.","journal-title":"MBio"},{"issue":"1","key":"2053_CR28","doi-asserted-by":"publisher","first-page":"e0143109","DOI":"10.1371\/journal.pone.0143109","volume":"11","author":"SC Francis","year":"2016","unstructured":"Francis SC, Hou Y, Baisley K, van de Wijgert J, Watson-Jones D, Ao TT, et al. Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection. PLoS ONE. 2016;11(1):e0143109.","journal-title":"PLoS ONE"},{"issue":"1","key":"2053_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAI.0000000000000533","volume":"69","author":"BL Guthrie","year":"2015","unstructured":"Guthrie BL, Introini A, Roxby AC, Choi RY, Bosire R, Lohman-Payne B, et al. Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women. J Acquir Immune Defic Syndr. 2015;69(1):1\u201310.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"2053_CR30","first-page":"571","volume":"102","author":"AK Ildgruben","year":"2003","unstructured":"Ildgruben AK, Sjoberg IM, Hammarstrom ML. Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium. Obstet Gynecol. 2003;102(3):571\u201382.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2053_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/QAI.0000000000000531","volume":"68","author":"KG Michel","year":"2015","unstructured":"Michel KG, Huijbregts RP, Gleason JL, Richter HE, Hel Z. Effect of hormonal contraception on the function of plasmacytoid dendritic cells and distribution of immune cell populations in the female reproductive tract. J Acquir Immune Defic Syndr. 2015;68(5):511\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"2053_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/QAI.0000000000000103","volume":"66","author":"C Morrison","year":"2014","unstructured":"Morrison C, Fichorova RN, Mauck C, Chen PL, Kwok C, Chipato T, et al. Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion. J Acquir Immune Defic Syndr. 2014;66(2):109\u201317.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2053_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jri.2015.03.007","volume":"110","author":"S Ngcapu","year":"2015","unstructured":"Ngcapu S, Masson L, Sibeko S, Werner L, McKinnon LR, Mlisana K, et al. Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive. J Reprod Immunol. 2015;110:14\u201321.","journal-title":"J Reprod Immunol"},{"issue":"4","key":"2053_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/QAI.0000000000000866","volume":"71","author":"AC Roxby","year":"2016","unstructured":"Roxby AC, Fredricks DN, Odem-Davis K, Asbjornsdottir K, Masese L, Fiedler TL, et al. Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate. J Acquir Immune Defic Syndr. 2016;71(4):359\u201366.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2053_CR35","doi-asserted-by":"crossref","unstructured":"Smith-McCune KK, Hilton JF, Shanmugasundaram U, Critchfield JW, Greenblatt RM, Seidman D, et al. Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibility. Mucosal Immunol. 2017.","DOI":"10.1038\/mi.2016.121"},{"issue":"4","key":"2053_CR36","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/infdis\/jiu176","volume":"210","author":"CM Mitchell","year":"2014","unstructured":"Mitchell CM, McLemore L, Westerberg K, Astronomo R, Smythe K, Gardella C, et al. Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells. J Infect Dis. 2014;210(4):651\u20135.","journal-title":"J Infect Dis"},{"key":"2053_CR37","doi-asserted-by":"crossref","unstructured":"Achilles SL, Creinin MD, Stoner KA, Chen BA, Meyn L, Hillier SL. Changes in genital tract immune cell populations after initiation of intrauterine contraception. Am J Obstet Gynecol. 2014;211(5):489 e1\u20139.","DOI":"10.1016\/j.ajog.2014.05.016"},{"issue":"2","key":"2053_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/QAI.0b013e31828decf8","volume":"63","author":"JS Coleman","year":"2013","unstructured":"Coleman JS, Mwachari C, Balkus J, Sanguli L, Muliro A, Agnew K, et al. Effect of the levonorgestrel intrauterine device on genital HIV-1 RNA shedding among HIV-1-infected women not taking antiretroviral therapy in Nairobi. Kenya J Acquir Immune Defic Syndr. 2013;63(2):245\u20138.","journal-title":"Kenya J Acquir Immune Defic Syndr"},{"issue":"11","key":"2053_CR39","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1093\/humrep\/del264","volume":"21","author":"O Heikinheimo","year":"2006","unstructured":"Heikinheimo O, Lehtovirta P, Suni J, Paavonen J. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women\u2013effects on bleeding patterns, ovarian function and genital shedding of HIV. Hum Reprod. 2006;21(11):2857\u201361.","journal-title":"Hum Reprod"},{"issue":"3","key":"2053_CR40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.contraception.2011.09.001","volume":"85","author":"R Samir","year":"2012","unstructured":"Samir R, Asplund A, Tot T, Pekar G, Hellberg D. Oral contraceptive and progestin-only use correlates to tissue tumor marker expression in women with cervical intraepithelial neoplasia. Contraception. 2012;85(3):288\u201393.","journal-title":"Contraception"},{"issue":"2","key":"2053_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/aji.12535","volume":"76","author":"U Shanmugasundaram","year":"2016","unstructured":"Shanmugasundaram U, Hilton JF, Critchfield JW, Greenblatt RM, Giudice LC, Averbach S, et al. Effects of the levonorgestrel-releasing intrauterine device on the immune microenvironment of the human cervix and endometrium. Am J Reprod Immunol. 2016;76(2):137\u201348.","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"2053_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1095\/biolreprod.114.122887","volume":"92","author":"A Tjernlund","year":"2015","unstructured":"Tjernlund A, Carias AM, Andersson S, Gustafsson-Sanchez S, Rohl M, Petersson P, et al. Progesterone-based intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1 mRNA expression. Biol Reprod. 2015;92(3):68.","journal-title":"Biol Reprod"},{"issue":"4","key":"2053_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010197","volume":"5","author":"S Srinivasan","year":"2010","unstructured":"Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS ONE. 2010;5(4): e10197.","journal-title":"PLoS ONE"},{"issue":"12","key":"2053_CR44","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1172\/JCI57172","volume":"121","author":"RM Brotman","year":"2011","unstructured":"Brotman RM. Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Invest. 2011;121(12):4610\u20137.","journal-title":"J Clin Invest"},{"key":"2053_CR45","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel J, Gajera P, Abdob Z, Schneiderc GM, Koeniga SS, McCullea SL, et al. Vaginal Microbiome of Reproductive-Age Women. Proc Natl Acad Sci. 2011;108:4680\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"2053_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/01.AOG.0000247627.84791.91","volume":"109","author":"JE Allsworth","year":"2007","unstructured":"Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001\u20132004 National Health and Nutrition Examination Survey data. Obstet Gynecol. 2007;109(1):114\u201320.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"2053_CR47","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1089\/aid.2015.0006","volume":"31","author":"AR Thurman","year":"2015","unstructured":"Thurman AR, Kimble T, Herold B, Mesquita PM, Fichorova RN, Dawood HY, et al. Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity. AIDS Res Hum Retroviruses. 2015;31(11):1139\u201352.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"2053_CR48","first-page":"431","volume":"96","author":"L Miller","year":"2000","unstructured":"Miller L, Patton DL, Meier A, Thwin SS, Hooton TM, Eschenbach DA. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol. 2000;96(3):431\u20139.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2053_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000416","volume":"8","author":"N Low","year":"2011","unstructured":"Low N, Chersich MF, Schmidlin K, Egger M, Francis SC, van de Wijgert JH, et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med. 2011;8(2): e1000416.","journal-title":"PLoS Med"},{"key":"2053_CR50","doi-asserted-by":"crossref","unstructured":"Van de Wijgert JH, Verwijs MC, Turner AN, Morrison CS. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission. AIDS. 2013.","DOI":"10.1097\/QAD.0b013e32836290b6"},{"issue":"6","key":"2053_CR51","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.autrev.2015.02.004","volume":"14","author":"IJ Tan","year":"2015","unstructured":"Tan IJ, Peeva E, Zandman-Goddard G. Hormonal modulation of the immune system - A spotlight on the role of progestogens. Autoimmun Rev. 2015;14(6):536\u201342.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2053_CR52","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/brv.12243","volume":"92","author":"YZ Foo","year":"2017","unstructured":"Foo YZ, Nakagawa S, Rhodes G, Simmons LW. The effects of sex hormones on immune function: a meta-analysis. Biol Rev Camb Philos Soc. 2017;92(1):551\u201371.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"1","key":"2053_CR53","first-page":"95","volume":"19","author":"TC Chao","year":"1996","unstructured":"Chao TC. Female sex hormones and the immune system. Changgeng Yi Xue Za Zhi. 1996;19(1):95\u2013106.","journal-title":"Changgeng Yi Xue Za Zhi"},{"key":"2053_CR54","unstructured":"Ansar Ahmed S, Penhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol. 1985;121(3)."},{"issue":"3","key":"2053_CR55","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/AOG.0000000000003404","volume":"134","author":"LB Haddad","year":"2019","unstructured":"Haddad LB, Wall KM, Tote K, Kilembe W, Vwalika B, Sharky T, et al. Hormonal contraception does not increase the risk of vaginal infections among a cohort of HIV serodiscordant couples in Lusaka. Zambia Obstet Gynecol. 2019;134(3):573\u201380.","journal-title":"Zambia Obstet Gynecol"},{"issue":"5","key":"2053_CR56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/QAD.0000000000001741","volume":"32","author":"LB Haddad","year":"2018","unstructured":"Haddad LB, Wall KM, Kilembe W, Vwalika B, Khu NH, Brill I, et al. Bacterial vaginosis modifies the association between hormonal contraception and HIV acquisition. AIDS (London, England). 2018;32(5):595\u2013604.","journal-title":"AIDS (London, England)"},{"key":"2053_CR57","doi-asserted-by":"crossref","unstructured":"Gajer P, Brotman RM, Bai G, Sakamoto J, Sch\u00fctte U, Zhong X, et al. Temporal dynamics of the human vaginal microbiota. Sci Trans Med. 2012;4(132).","DOI":"10.1126\/scitranslmed.3003605"},{"issue":"2","key":"2053_CR58","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301.1991","volume":"29","author":"RPKM Nugent","year":"1991","unstructured":"Nugent RPKM, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram strain interpretation. J Clin Microbiol. 1991;29(2):297\u2013301.","journal-title":"J Clin Microbiol"},{"key":"2053_CR59","doi-asserted-by":"crossref","unstructured":"Masopust D, Vezys V, L. MA, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 2001;291(5512):2413\u20137.","DOI":"10.1126\/science.1058867"},{"issue":"3","key":"2053_CR60","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1046\/j.0022-202x.2001.01481.x","volume":"117","author":"K Pauls","year":"2001","unstructured":"Pauls K, Sch\u00f6n M, Kubitza RC, Homey B, Wiesenborn A, Lehmann P, et al. Role of integrin alphaE(CD103)beta7 for tissue-specific epidermal localization of CD8+ T lymphocytes. J Invest Dermatol. 2001;117(3):569\u201375.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2053_CR61","doi-asserted-by":"publisher","first-page":"8536","DOI":"10.1038\/s41598-017-09113-4","volume":"7","author":"D Kobayashi","year":"2017","unstructured":"Kobayashi D, Endo M, Ochi H, Hojo H, Miyasaka M, Hayasaka H. Regulation of CCR7-dependent cell migration through CCR7 homodimer formation. Sci Rep. 2017;7(1):8536.","journal-title":"Sci Rep"},{"issue":"3","key":"2053_CR62","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/mi.2012.7","volume":"5","author":"J Lajoie","year":"2012","unstructured":"Lajoie J, Juno J, Burgener A, Rahman S, Mogk K, Wachihi C, et al. A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunol. 2012;5(3):277\u201387.","journal-title":"Mucosal Immunol"},{"issue":"2","key":"2053_CR63","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cid\/civ298","volume":"61","author":"L Masson","year":"2015","unstructured":"Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, et al. Genital inflammation and the risk of HIV acquisition in women. Clin Infect Dis. 2015;61(2):260\u20139.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2053_CR64","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1136\/sextrans-2014-051601","volume":"90","author":"L Masson","year":"2014","unstructured":"Masson L, Mlisana K, Little F, Werner L, Mkhize NN, Ronacher K, et al. Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study. Sex Transm Infect. 2014;90(8):580\u20137.","journal-title":"Sex Transm Infect"},{"key":"2053_CR65","first-page":"199","volume":"306","author":"AM Cole","year":"2006","unstructured":"Cole AM. Innate host defense of human vaginal and cervical mucosae. Curr Top Microbiol Immunol. 2006;306:199\u2013230.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"4","key":"2053_CR66","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/QAD.0b013e328013d9b5","volume":"21","author":"MJ Keller","year":"2007","unstructured":"Keller MJ, Guzman E, Hazrati E, Kasowitz A, Cheshenko N, Wallenstein S, et al. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS. 2007;21(4):467\u201376.","journal-title":"AIDS"},{"issue":"3","key":"2053_CR67","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1067\/mob.2002.125280","volume":"187","author":"EV Valore","year":"2002","unstructured":"Valore EV, Park CH, Igreti SL, Ganz T. Antimicrobial components of vaginal fluid. Am J Obstet Gynecol. 2002;187(3):561\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2053_CR68","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1067\/mob.2002.123034","volume":"187","author":"M Hein","year":"2002","unstructured":"Hein M, Valore EV, Helmig RB, Uldbjerg N, Ganz T. Antimicrobial factors in the cervical mucus plug. Am J Obstet Gynecol. 2002;187(1):137\u201344.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"2053_CR69","doi-asserted-by":"publisher","first-page":"7560","DOI":"10.4049\/jimmunol.175.11.7560","volume":"175","author":"N Venkataraman","year":"2005","unstructured":"Venkataraman N, Cole AL, Svoboda P, Pohl J, Cole AM. Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. J Immunol. 2005;175(11):7560\u20137.","journal-title":"J Immunol"},{"issue":"1","key":"2053_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016475","volume":"6","author":"MJ Keller","year":"2011","unstructured":"Keller MJ, Madan RP, Torres NM, Fazzari MJ, Cho S, Kalyoussef S, et al. A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel. PLoS ONE. 2011;6(1): e16475.","journal-title":"PLoS ONE"},{"key":"2053_CR71","doi-asserted-by":"crossref","unstructured":"Keller MJ, Mesquita PM, Torres NM, Cho S, Shust G, Madan RP, et al. Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials. PLoS One. 2010;5(1):e8781.","DOI":"10.1371\/journal.pone.0008781"},{"key":"2053_CR72","doi-asserted-by":"crossref","unstructured":"Kalyoussef S, Nieves E, Dinerman E, Carpenter C, Shankar V, Oh J, et al. Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretions. PLoS One. 2012;7(11):e49506.","DOI":"10.1371\/journal.pone.0049506"},{"issue":"6","key":"2053_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011366","volume":"5","author":"M Ghosh","year":"2010","unstructured":"Ghosh M, Fahey JV, Shen Z, Lahey T, Cu-Uvin S, Wu Z, et al. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS ONE. 2010;5(6): e11366.","journal-title":"PLoS ONE"},{"issue":"4","key":"2053_CR74","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.contraception.2018.01.015","volume":"97","author":"SW Blue","year":"2018","unstructured":"Blue SW, Winchell AJ, Kaucher AV, Lieberman RA, Gilles CT, Pyra MN, et al. Simultaneous quantitation of multiple contraceptive hormones in human serum by LC-MS\/MS. Contraception. 2018;97(4):363\u20139.","journal-title":"Contraception"},{"key":"2053_CR75","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/1471-2105-7-371","volume":"7","author":"C Lozupone","year":"2006","unstructured":"Lozupone C, Hamady M, Knight R. UniFrac\u2013an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics. 2006;7:371.","journal-title":"BMC Bioinformatics"},{"key":"2053_CR76","doi-asserted-by":"crossref","unstructured":"Haddad LB, Swaims-Kohlmeier A, Mehta CC, Haaland RE, Brown NL, Sheth AN, et al. Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood. PloS one [Internet]. 2020 2020; 15(3):[e0230473 p.].","DOI":"10.1371\/journal.pone.0230473"},{"key":"2053_CR77","unstructured":"Haddad L, Kohlmeier A, Haaland R, Brown N, Lupo D, Mehta C, et al. Changes in genital tract HIV target cells with three progestin-based contraceptives. 24th Conference on Retroviruses and Opportunistic Infections; February 13\u201316, 2017; Seattle, WA2017."},{"issue":"1","key":"2053_CR78","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4049\/jimmunol.1502628","volume":"197","author":"A Swaims-Kohlmeier","year":"2016","unstructured":"Swaims-Kohlmeier A, Haaland RE, Haddad LB, Sheth AN, Evans-Strickfaden T, Lupo LD, et al. Progesterone Levels Associate with a Novel Population of CCR5+CD38+ CD4 T Cells Resident in the Genital Mucosa with Lymphoid Trafficking Potential. J Immunol. 2016;197(1):368\u201376.","journal-title":"J Immunol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-02053-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-02053-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-02053-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T20:10:09Z","timestamp":1668888609000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-02053-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2053"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-02053-w","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"25 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent, and the study was conducted in accordance with the Declaration of Helsinki. The study has been reviewed and approved by the Emory University Institutional Review Board (IRB00104017) and the Grady Health System Research Oversight Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The following authors declare no competing interests: AKS, LBH, CCM, TSS, GBH, MRY, SG, VV.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"456"}}